SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

CHE

Chemed Corporation
NYSEHealth Care

Latest close: 512.38 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 28, 2026Reported sale · Form 4KEVIN J MCNAMARA, president and CEO · $1.0MOpen the filing ↗
  2. Sep 28, 2026Notice of sale · Form 144Kevin McNamara · Officer · $1.1MOpen the filing ↗
  3. Sep 23, 2026Notice of sale · Form 144MCNAMARA KEVIN J · Officer · $998.0KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,74910 flagged findings
Reported transactions (Form 4)80since Feb 14, 2025 · and 8 other holdings
Corporate events (8-K)30since May 17, 2007

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-04-28capital return (buybacks/dividends)recentOpen filing ↗
    “…repurchased the following capital stock: Three months ended March 31, 2026 2025 Total cost of repurchased shares (in thousands) $…”
    +1 more passage from the same document
    • “…shares (in thousands) $ 197,682 $ 29,756 Shares repurchased 500,000 50,000 Weighted average price per share $ 395.36 $…”
  • 2026-04-28health plan compliance riskrecentOpen filing ↗
    “…Services (“OAS”) for inclusion in an audit of the provision of elevated level-of-care hospice services, which reviewed 100 out of a…”
  • 2026-02-27share offering or dilution eventrecentOpen filing ↗
    “…that period. Customer Concentration Roto-Rooter’s business has a large and diverse customer base. Over 90% of VITAS’ revenue is from…”
    +1 more passage from the same document
    • “…that we currently deem to be immaterial may also materially and adversely affect our business, financial condition, or results of…”
  • 2026-02-27capital return (buybacks/dividends)recentOpen filing ↗
    “…2024. In 2025, we repurchased 932,500 shares of Chemed capital stock at a weighted average price of $459.02 per share. In 2024, we…”
    +1 more passage from the same document
    • “…2024 and 2023. In 2024, we repurchased 638,235 shares of Chemed capital stock at a weighted average price of $562.08 per share. In…”
  • 2026-02-27Department of Justice inquiryrecentOpen filing ↗
    “…governmental scrutiny. The Company cannot predict what, if any, changes may be implemented in coverage, reimbursement, or…”
    +1 more passage from the same document
    • “…10.25 Form of Stock Option Grant, 2013.*,** 10.26 Form of Stock Option Grant, 2015. *,** 10.27 Form of Stock Option Grant, 2018.…”
  • 2026-02-27health plan compliance riskrecentOpen filing ↗
    “…Services (“OAS”) for inclusion in an audit of the provision of elevated level-of-care hospice services, which reviewed 100 out of a…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,749)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Notice of proposed sale · 2 Form 144 filingsshow all 2hide
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Aug 21, 26Form 144 ↗Notice of proposed sale
  • Aug 12, 26SCHEDULE 13G ↗Passive stake · AQR Capital Management, LLC · 7.3% · event on Jun 30, 26
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Aug 3, 26Form 144 ↗Notice of proposed sale
  • Aug 3, 26Form 4 ↗Insider transaction
  • Jul 31, 26Form 144 ↗Notice of proposed sale
  • Jul 31, 2610-Q ↗Quarterly report
  • Jul 28, 268-K ↗Current report · Results
  • Insider transaction · 7 Form 4 filingsshow all 7hide

1,749 filings on record, the oldest from Feb 10, 94.

Listing the 25 most recent filings of the 1,749 on record.

8-Ks, explained

Stress2Structure28Governance13
  • Apr 13, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jul 29, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 17, 24StructureCompleted an acquisition or disposal8-K 2.01 ↗
  • Governance5 senior executive changes2022 – 2024show all 5hide
    • Feb 1, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Dec 18, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Nov 3, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Nov 7, 22GovernanceA senior executive left or was appointed8-K/A 5.02 ↗
    • Aug 5, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jun 29, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Sep 1, 20GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Sep 17, 19StructureCompleted an acquisition or disposal+1 more in the same filing8-K 2.01 ↗
  • Jun 22, 18StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Nov 2, 17StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Apr 3, 17GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jun 9, 16GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Structure3 material agreements entered2011 – 2014show all 3hide
    • Jul 2, 14StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Jan 22, 13StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Mar 1, 11StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

4 older filings not shown · The record reaches back to Dec 29, 04.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Oct 2, 06StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Dec 29, 04StressRestructuring plan with committed costs8-K 2.05 ↗

The full record holds 2 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • AQR Capital Management, LLC7.3%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Vanguard Portfolio Management5.9%Mar 31, 26SCHEDULE 13G ↗
  • Vanguard Capital Management5.4%Mar 31, 26SCHEDULE 13G ↗

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Sep 28, Kevin McNamara filed notice of intent to sell up to $1.1M. That is about 0.02% of shares outstanding.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $1.0M on Sep 28, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+4 more recent notices · 3 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 28, 26Sell$1.0MKEVIN J MCNAMARApresident and CEO↗
  • Sep 18, 26Sell$1.0MKEVIN J MCNAMARApresident and CEO↗
  • Aug 21, 26Sell$1.1MKEVIN J MCNAMARApresident and CEO↗
  • Aug 21, 26Sell$541KSPENCER S LEEexecutive vice president↗
  • Aug 3, 26Sell$1.1MKEVIN J MCNAMARApresident and CEO↗
  • Jul 31, 26Sell$101KPATRICK P GRACE↗
  • Jun 9, 26Sell$603KANDREA R LINDELL↗
  • May 29, 26Sell$219KGEORGE J WALSH III↗
  • May 8, 26Sell$26KPATRICK P GRACE↗
  • May 1, 26Sell$842KKEVIN J MCNAMARApresident and CEO↗
  • Mar 27, 26Sell$554KKEVIN J MCNAMARApresident and CEO↗
  • Mar 12, 26Sell$806KKEVIN J MCNAMARApresident and CEO↗
Stock compensation, tax and giftsshow the 28 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 30, 26Compensation$5.4MSPENCER S LEEexecutive vice president↗
  • Sep 30, 26Tax$5.7MSPENCER S LEEexecutive vice president↗
  • Sep 28, 26Compensation$2.1MTHOMAS C HUTTONvice president↗
  • Sep 28, 26Tax$2.2MTHOMAS C HUTTONvice president↗
  • Aug 10, 26Compensation$3.0MBrian C JudkinsVP and Chief Legal Officer↗
  • Aug 10, 26Tax$3.2MBrian C JudkinsVP and Chief Legal Officer↗
  • Aug 5, 26Compensation$1.2MJoel L WherleyCEO - Vitas Healthcare↗
  • Aug 5, 26Tax$1.2MJoel L WherleyCEO - Vitas Healthcare↗
  • Jul 31, 26Compensation$891KKEVIN J MCNAMARApresident and CEO↗
  • Jul 31, 26Tax$10.5MKEVIN J MCNAMARApresident and CEO↗
  • May 18, 26Compensation$170KRon DeLyons↗
  • May 18, 26Compensation$170KPATRICK P GRACE↗
  • May 18, 26Compensation$170KChristopher J Heaney↗
  • May 18, 26Compensation$170KANDREA R LINDELL↗
  • May 18, 26Compensation$170KEileen P McCarthy↗
  • May 18, 26Compensation$170KJohn Meredith Mount Jr.↗
  • May 18, 26Compensation$170KGEORGE J WALSH III↗
  • Feb 13, 26Compensation$165KBrian C JudkinsVP and Chief Legal Officer↗
  • Feb 13, 26Compensationamount n/aBrian C JudkinsVP and Chief Legal Officer↗
  • Feb 13, 26Tax$48KBrian C JudkinsVP and Chief Legal Officer↗
  • Feb 13, 26Compensation$1.3MKEVIN J MCNAMARApresident and CEO↗
  • Feb 13, 26Compensationamount n/aKEVIN J MCNAMARApresident and CEO↗
  • Feb 13, 26Tax$560KKEVIN J MCNAMARApresident and CEO↗
  • Feb 13, 26Compensation$194KMichael D WitzemanVP & Chief Financial Officer↗
  • Feb 13, 26Compensationamount n/aMichael D WitzemanVP & Chief Financial Officer↗
  • Feb 13, 26Tax$56KMichael D WitzemanVP & Chief Financial Officer↗
  • Feb 13, 26Compensation$128KJoel L WherleyCEO - Vitas Healthcare↗
  • Feb 13, 26Compensationamount n/aJoel L WherleyCEO - Vitas Healthcare↗

The full record holds 231 transactions and goes back to Mar 10, 04.

Its sector and its market

Chemed Corporation among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Chemed Corporation, the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Chemed Corporation in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
1,749 documents on file, from Feb 10, 1994 to Oct 1, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.